Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

Autor: Abalos, Karina, Accini, Jose, Aloysia, Naveena, Amuasi, John Humphrey, Ansah, Nana Akosua, Benkeser, David, Berge, Aude, Beyko, Hanna, Bilotkach, Oleksandra, Breuer, Thomas, Bonfanti, Alberto Cadena, Bukusi, Elisabeth, Canter, Richard, Carrillo, Jaime Augusto, Chansinghakul, Danaya, Coux, Florence, Das, Chandan, Das, Santa Kumar, Devlin, Louis, Espinoza, Luis, Fay, Michael, Follmann, Dean, Frago, Carina, Garinga, Agnes, Gilbert, Peter B, Gonzalez, Claudia, Granados, Maria Angelica, Guillery, Lea, Huang, Ying, Hudzina, Kathy, Jain, Manish, Kanodia, Piush, Khandelwal, Nitin, Mutuluuza, Cissy Kityo, Kiweewa, Francis, Kiwanuka, Noah, Kosolsak, Chalit, Kukian, Darshna, Kushwaha, Jitendra Singh, Laot, Thelma, Lopez-Medina, Eduardo, Macareno Arroyo, Hugo, Mandaliya, Kishorchandra, Mamod, Stephanie, Mangarule, Somnath, Martínez, Javier, McClelland, Scott, Menard, Lisa, Mendoza, Sandra, Mohapatra, Satyajit, Moreau, Catherine, Mugo, Nelly, Nduba, Videlis, Noriega, Fernando, Ntege, Patricia Nahirya, Okech, Brenda, Otero, Maria, Ouma, Samuel Gurrion, Oyieko, Janet, Paredes, Mercedes, Pardo, Erwin, Postol, Svitlana, Pekala, David, Peng, Penny, Py, Marie-Laure, Rivas, Enrique, Rivero, Rafael, Rodriguez, Edith, Saleh, Mansoor, Sánchez, Pedro, Sater, Nessryne, Shah, Jinen, Shrestha, Rajeev, Siika, Abraham, Singh, Chandramani, Singh, Veer Bahadur, Tamrakar, Dipesh, Tavares Da-Silva, Fernanda, Otieno Tina, Lucas, Velasquez, Hector, Wabwire, Deo, Wajja, Anne, Zaworski, Elodie, Zhang, Nianxian, Dayan, Gustavo H ^{*, *}, Rouphael, Nadine ^*, Walsh, Stephen R ^*, Chen, Aiying, Grunenberg, Nicole, Allen, Mary, Antony, Johannes, Asante, Kwaku Poku, Bhate, Amit Suresh, Beresnev, Tatiana, Bonaparte, Matthew I, Celle, Médéric, Ceregido, Maria Angeles, Corey, Lawrence, Dobrianskyi, Dmytro, Fu, Bo, Grillet, Marie-Helene, Keshtkar-Jahromi, Maryam, Juraska, Michal, Kee, Jia Jin, Kibuuka, Hannah, Koutsoukos, Marguerite, Masotti, Roger, Michael, Nelson L, Neuzil, Kathleen M, Reynales, Humberto, Robb, Merlin L, Villagómez Martínez, Sandra M, Sawe, Fredrick, Schuerman, Lode, Tong, Tina, Treanor, John, Wartel, T Anh, Diazgranados, Carlos A, Chicz, Roman M, Gurunathan, Sanjay, Savarino, Stephen, Sridhar, Saranya

Publikováno v: In The Lancet Respiratory Medicine November 2023 11(11):975-990

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin^®).

Autor: Singh, Chandramani, Verma, Savita, Reddy, Prabhakar, Diamond, Michael S., Curiel, David T., Patel, Chintan, Jain, Manish Kumar, Redkar, Sagar Vivek, Bhate, Amit Suresh, Gundappa, Vivek, Konatham, Rambabu, Toppo, Leelabati, Joshi, Aniket Chandrakant, Kushwaha, Jitendra Singh, Singh, Ajit Pratap, Bawankule, Shilpa, Ella, Raches, Prasad, Sai, Ganneru, Brunda, Chiteti, Siddharth Reddy

Publikováno v: NPJ Vaccines; 8/18/2023, Vol. 8 Issue 1, p1-9, 9p

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.

Autor: Dayan GH; Sanofi, Swiftwater, PA, USA., Rouphael N; Emory University Hop eClininc, Atlanta, GA, USA., Walsh SR; Harvard Medical School, Boston, MA, USA., Chen A; Sanofi, Swiftwater, PA, USA., Grunenberg N; Fred Hutchinson Cancer Center, Seattle, WA, USA., Allen M; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MA, USA., Antony J; Sanofi, Frankfurt, Germany., Asante KP; Research and Development Division, Ghana Health Service, Kintampo North Municipality, Ghana., Bhate AS; Jeevan Rekha Hospital, Belgavi, India., Beresnev T; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MA, USA., Bonaparte MI; Sanofi, Swiftwater, PA, USA., Ceregido MA; GSK, Wavre, Belgium., Dobrianskyi D; Medical Centre, Medical Clinic Blagomed LLC, Kyiv, Ukraine., Fu B; Sanofi, Swiftwater, PA, USA., Grillet MH; Sanofi, Lyon, France., Keshtkar-Jahromi M; National Institute of Health, Rockville, Maryland.; John Hopkins University School of Medicine, Baltimore, Maryland., Juraska M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kee JJ; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kibuuka H; Makerere University Walter Reed Project, Kampala, Uganda., Koutsoukos M; GSK, Wavre, Belgium., Masotti R; Sanofi, Swiftwater, PA, USA., Michael NL; Walter Reed Army Institute of Research, MD, USA., Reynales H; Centro de Attencion e Investigation Medica S.A.S. - Caimed Chía, Chía, Colombia., Robb ML; The Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MA, USA., Villagómez Martínez SM; Hospital de Temixco en acuerdo con el Instituto Nacional de Pediatria, México., Sawe F; Kenya Medical Research Institute - US Army Medical Research, Kisumu, Kenya., Schuerman L; GSK, Wavre, Belgium., Tong T; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MA, USA., Treanor J; Tunnell Government Services in support of Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Wartel TA; International Vaccine Institute, Seoul, South Korea., Diazgranados CA; Sanofi, Swiftwater, PA, USA., Chicz RM; Sanofi, Cambridge, MA, USA., Gurunathan S; Sanofi, Swiftwater, PA, USA., Savarino S; Sanofi, Swiftwater, PA, USA., Sridhar S; Sanofi, Reading, UK.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Jan 13. Date of Electronic Publication: 2023 Jan 13.